Pesquisas alternativas:
addict its » addict it's (Expandir a Pesquisa), addict rats (Expandir a Pesquisa), addict i (Expandir a Pesquisa)
j addict » _ addict (Expandir a Pesquisa), r addict (Expandir a Pesquisa), et addict (Expandir a Pesquisa)
its ther » its other (Expandir a Pesquisa), its theory (Expandir a Pesquisa), its others (Expandir a Pesquisa)
addict its » addict it's (Expandir a Pesquisa), addict rats (Expandir a Pesquisa), addict i (Expandir a Pesquisa)
j addict » _ addict (Expandir a Pesquisa), r addict (Expandir a Pesquisa), et addict (Expandir a Pesquisa)
its ther » its other (Expandir a Pesquisa), its theory (Expandir a Pesquisa), its others (Expandir a Pesquisa)
1
Por Zvolensky, Michael J., Garey, Lorra, Rogers, Andrew H., Schmidt, Norman B., Vujanovic, Anka A., Storch, Eric A., Buckner, Julia D., Paulus, Daniel J., Alfano, Candice, Smits, Jasper A.J., O'Cleirigh, Conall
Publicado no Behav Res Ther (2020)
Obter o texto integralPublicado no Behav Res Ther (2020)
Obter o texto integral
Obter o texto integral
Artigo
2
Por El Fatimy, Rachid, Subramanian, Shruthi, Uhlmann, Erik J., Krichevsky, Anna M.
Publicado no Mol Ther (2017)
“.... Oncogenic microRNA-10b (miR-10b) is strongly and universally upregulated in GBM, and its inhibition...”Publicado no Mol Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... there are currently no effective pharmacotherapies for the treatment of METH addiction. METH is potent psychostimulant...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Downs, BW, Oscar-Berman, M, Waite, RL, Madigan, MA, Giordano, J, Beley, T, Jones, S, Simpatico, T, Hauser, M, Borsten, J, Marcelo, F, Braverman, ER, Lohmann, R, Dushaj, K, Helman, M, Barh, D, Schoenthaler, ST, Han, D, Blum, K
Publicado em 2013
“... it “Reward Deficiency Solution System” providing evidence for its adoption....”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Rojo-Mota, Gloria, Pedrero-Pérez, Eduardo J., Ruiz-Sánchez de León, José M., León-Frade, Irene, Aldea-Poyo, Patricia, Alonso-Rodríguez, Marina, Pedrero-Aguilar, Jara, Morales-Alonso, Sara
Publicado no Occup Ther Int (2017)
“... that explores its use in addiction treatment. OBJECTIVES OF STUDY: To explore the convergent validity of LOTCA...”Publicado no Occup Ther Int (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Hicks, Martin J, De, Bishnu P, Rosenberg, Jonathan B, Davidson, Jesse T, Moreno, Amira Y, Janda, Kim D, Wee, Sunmee, Koob, George F, Hackett, Neil R, Kaminsky, Stephen M, Worgall, Stefan, Toth, Miklos, Mezey, Jason G, Crystal, Ronald G
Publicado em 2011
“...Based on the concept that anticocaine antibodies could prevent inhaled cocaine from reaching its...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“...Tobacco use is a major health problem, and nicotine is the main addictive component. Nicotine binds...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“...The glial cell line-derived neurotrophic factor (GDNF) is a secreted protein, best known for its...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... of social confrontations in adolescence and adulthood, to continuous subordination stress, each with its own...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... and rewarding effects of addictive drugs. Next we identify key knowledge gaps and suggest new tools...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Berg, Jeannette Zinggeler, Mason, Jesse, Boettcher, Angela J., Hatsukami, Dorothy K., Murphy, Sharon E.
Publicado em 2010
“...Nicotine is the major addictive agent in tobacco smoke, and it is metabolized extensively...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Sneider, Jennifer T., Cohen-Gilbert, Julia E., Crowley, David J., Paul, Margot D., Silveri, Marisa M.
Publicado em 2013
“... adults has not systematically investigated its potential negative impacts on visuospatial memory...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Mescollotto, Fabiana Foltran, Castro, Ester Moreira de, Pelai, Elisa Bizetti, Pertille, Adriana, Bigaton, Delaine Rodrigues
Publicado no Braz J Phys Ther (2019)
“...BACKGROUND: Smartphone use has been constantly increasing. Smartphone addiction can lead to changes...”Publicado no Braz J Phys Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Bickel, Warren K., Jarmolowicz, David P., Mueller, E. Terry, Koffarnus, Mikhail N., Gatchalian, Kirstin M.
Publicado em 2012
“...Delay discounting describes the devaluation of a reinforcer as a function of the delay until its...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Frankel, Paul S., Hoonakker, Amanda J., Alburges, Mario E., McDougall, Jacob W., McFadden, Lisa M., Fleckenstein, Annette E., Hanson, Glen R.
Publicado em 2011
“... of the problems associated with abuse of METH are related to its profound actions on dopamine (DA) basal ganglia...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Thompson, A.L., Grenald, S.A., Ciccone, H.A., BassiriRad, N., Niphakis, M.J., Cravatt, B.F., Largent-Milnes, T.M., Vanderah, T.W.
Publicado no J Pharmacol Exp Ther (2020)
“.... In addition, MJN110 maintains its efficacy in a chronic-dosing paradigm over the course of 7 days without...”Publicado no J Pharmacol Exp Ther (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Huang, Qingling, Schneeberger, Valentina E., Luetteke, Noreen, Jin, Chengliu, Afzal, Roha, Budzevich, Mikalai M., Makanji, Rikesh J., Martinez, Gary V., Shen, Tao, Zhao, Lichao, Fung, Kar-Ming, Haura, Eric B., Coppola, Domenico, Wu, Jie
Publicado no Mol Cancer Ther (2016)
“... was identified as the most potent inhibitor against KIF5B-RET and its drug-resistant mutants. Interestingly...”Publicado no Mol Cancer Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Wilkerson, Jenny L., Niphakis, Micah J., Grim, Travis W., Mustafa, Mohammed A., Abdullah, Rehab A., Poklis, Justin L., Dewey, William L., Akbarali, Hamid, Banks, Matthew L., Wise, Laura E., Cravatt, Benjamin F., Lichtman, Aron H.
Publicado no J Pharmacol Exp Ther (2016)
“... constipation, respiratory depression, pruritus, tolerance, abuse, and addiction. A recognized strategy...”Publicado no J Pharmacol Exp Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Hussmann, G. Patrick, Turner, Jill R., Lomazzo, Ermelinda, Venkatesh, Rashmi, Cousins, Vanessa, Xiao, Yingxian, Yasuda, Robert P., Wolfe, Barry B., Perry, David C., Rezvani, Amir H., Levin, Edward D., Blendy, Julie A., Kellar, Kenneth J.
Publicado em 2012
“... that were ∼150 times its affinity for α4β2* nAChRs and occupied at least 75% of nAChRs. Thus, chronic...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Chakrabarti, Sumita, Liu, Nai-Jiang, Zadina, James E., Sharma, Tarak, Gintzler, Alan R.
Publicado em 2012
“... utility of using sex-specific treatments for addiction that harness the activity of endogenous opioids....”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo